221 related articles for article (PubMed ID: 21712824)
1. Methylator phenotype of malignant germ cell tumours in children identifies strong candidates for chemotherapy resistance.
Jeyapalan JN; Noor DA; Lee SH; Tan CL; Appleby VA; Kilday JP; Palmer RD; Schwalbe EC; Clifford SC; Walker DA; Murray MJ; Coleman N; Nicholson JC; Scotting PJ
Br J Cancer; 2011 Aug; 105(4):575-85. PubMed ID: 21712824
[TBL] [Abstract][Full Text] [Related]
2. The two most common histological subtypes of malignant germ cell tumour are distinguished by global microRNA profiles, associated with differential transcription factor expression.
Murray MJ; Saini HK; van Dongen S; Palmer RD; Muralidhar B; Pett MR; Piipari M; Thornton CM; Nicholson JC; Enright AJ; Coleman N
Mol Cancer; 2010 Nov; 9():290. PubMed ID: 21059207
[TBL] [Abstract][Full Text] [Related]
3. Differences in DNA methylation profiles by histologic subtype of paediatric germ cell tumours: a report from the Children's Oncology Group.
Williams LA; Mills L; Hooten AJ; Langer E; Roesler M; Frazier AL; Krailo M; Nelson HH; Bestrashniy J; Amatruda JF; Poynter JN
Br J Cancer; 2018 Oct; 119(7):864-872. PubMed ID: 30287918
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive genetic analysis of pediatric germ cell tumors identifies potential drug targets.
Kubota Y; Seki M; Kawai T; Isobe T; Yoshida M; Sekiguchi M; Kimura S; Watanabe K; Sato-Otsubo A; Yoshida K; Suzuki H; Kataoka K; Fujii Y; Shiraishi Y; Chiba K; Tanaka H; Hiwatari M; Oka A; Hayashi Y; Miyano S; Ogawa S; Hata K; Tanaka Y; Takita J
Commun Biol; 2020 Sep; 3(1):544. PubMed ID: 32999426
[TBL] [Abstract][Full Text] [Related]
5. The pioneer and differentiation factor FOXA2 is a key driver of yolk-sac tumour formation and a new biomarker for paediatric and adult yolk-sac tumours.
Wruck W; Bremmer F; Kotthoff M; Fichtner A; Skowron MA; Schönberger S; Calaminus G; Vokuhl C; Pfister D; Heidenreich A; Albers P; Adjaye J; Nettersheim D
J Cell Mol Med; 2021 Feb; 25(3):1394-1405. PubMed ID: 33448076
[TBL] [Abstract][Full Text] [Related]
6. Involvement of adenomatous polyposis coli (APC) gene in testicular yolk sac tumor of infants.
Kato N; Shibuya H; Fukase M; Tamura G; Motoyama T
Hum Pathol; 2006 Jan; 37(1):48-53. PubMed ID: 16360415
[TBL] [Abstract][Full Text] [Related]
7. Global DNA methylation analysis reveals miR-214-3p contributes to cisplatin resistance in pediatric intracranial nongerminomatous malignant germ cell tumors.
Hsieh TH; Liu YR; Chang TY; Liang ML; Chen HH; Wang HW; Yen Y; Wong TT
Neuro Oncol; 2018 Mar; 20(4):519-530. PubMed ID: 29036598
[TBL] [Abstract][Full Text] [Related]
8. DNA methylation analysis reveals distinct methylation signatures in pediatric germ cell tumors.
Amatruda JF; Ross JA; Christensen B; Fustino NJ; Chen KS; Hooten AJ; Nelson H; Kuriger JK; Rakheja D; Frazier AL; Poynter JN
BMC Cancer; 2013 Jun; 13():313. PubMed ID: 23806198
[TBL] [Abstract][Full Text] [Related]
9. DNMT3b overexpression contributes to a hypermethylator phenotype in human breast cancer cell lines.
Roll JD; Rivenbark AG; Jones WD; Coleman WB
Mol Cancer; 2008 Jan; 7():15. PubMed ID: 18221536
[TBL] [Abstract][Full Text] [Related]
10. Pediatric malignant germ cell tumors show characteristic transcriptome profiles.
Palmer RD; Barbosa-Morais NL; Gooding EL; Muralidhar B; Thornton CM; Pett MR; Roberts I; Schneider DT; Thorne N; Tavaré S; Nicholson JC; Coleman N;
Cancer Res; 2008 Jun; 68(11):4239-47. PubMed ID: 18519683
[TBL] [Abstract][Full Text] [Related]
11. Global DNA methylation in fetal human germ cells and germ cell tumours: association with differentiation and cisplatin resistance.
Wermann H; Stoop H; Gillis AJ; Honecker F; van Gurp RJ; Ammerpohl O; Richter J; Oosterhuis JW; Bokemeyer C; Looijenga LH
J Pathol; 2010 Aug; 221(4):433-42. PubMed ID: 20593487
[TBL] [Abstract][Full Text] [Related]
12. Cross platform analysis of methylation, miRNA and stem cell gene expression data in germ cell tumors highlights characteristic differences by tumor histology.
Poynter JN; Bestrashniy JR; Silverstein KA; Hooten AJ; Lees C; Ross JA; Tolar J
BMC Cancer; 2015 Oct; 15():769. PubMed ID: 26497383
[TBL] [Abstract][Full Text] [Related]
13. Novel epigenetically deregulated genes in testicular cancer include homeobox genes and SCGB3A1 (HIN-1).
Lind GE; Skotheim RI; Fraga MF; Abeler VM; Esteller M; Lothe RA
J Pathol; 2006 Dec; 210(4):441-9. PubMed ID: 17029216
[TBL] [Abstract][Full Text] [Related]
14. Frequent epigenetic inactivation of the RASSF1A tumour suppressor gene in testicular tumours and distinct methylation profiles of seminoma and nonseminoma testicular germ cell tumours.
Honorio S; Agathanggelou A; Wernert N; Rothe M; Maher ER; Latif F
Oncogene; 2003 Jan; 22(3):461-6. PubMed ID: 12545168
[TBL] [Abstract][Full Text] [Related]
15. Effects of DNMT1 silencing on malignant phenotype and methylated gene expression in cervical cancer cells.
Zhang Y; Chen FQ; Sun YH; Zhou SY; Li TY; Chen R
J Exp Clin Cancer Res; 2011 Oct; 30(1):98. PubMed ID: 21999220
[TBL] [Abstract][Full Text] [Related]
16. DNA methyltransferase-3 like protein expression in various histological types of testicular germ cell tumor.
Matsuoka T; Kawai K; Ando S; Sugita S; Kandori S; Kojima T; Miyazaki J; Nishiyama H
Jpn J Clin Oncol; 2016 May; 46(5):475-81. PubMed ID: 26917601
[TBL] [Abstract][Full Text] [Related]
17. Refractory testicular germ cell tumors are highly sensitive to the second generation DNA methylation inhibitor guadecitabine.
Albany C; Hever-Jardine MP; von Herrmann KM; Yim CY; Tam J; Warzecha JM; Shin L; Bock SE; Curran BS; Chaudhry AS; Kim F; Sandusky GE; Taverna P; Freemantle SJ; Christensen BC; Einhorn LH; Spinella MJ
Oncotarget; 2017 Jan; 8(2):2949-2959. PubMed ID: 27936464
[TBL] [Abstract][Full Text] [Related]
18. Hypermethylation of the RUNX3 gene promoter in testicular yolk sac tumor of infants.
Kato N; Tamura G; Fukase M; Shibuya H; Motoyama T
Am J Pathol; 2003 Aug; 163(2):387-91. PubMed ID: 12875960
[TBL] [Abstract][Full Text] [Related]
19. Identification of tumour-specific epigenetic events in medulloblastoma development by hypermethylation profiling.
Lindsey JC; Lusher ME; Anderton JA; Bailey S; Gilbertson RJ; Pearson AD; Ellison DW; Clifford SC
Carcinogenesis; 2004 May; 25(5):661-8. PubMed ID: 14688019
[TBL] [Abstract][Full Text] [Related]
20. High-throughput microRNAome analysis in human germ cell tumours.
Gillis AJ; Stoop HJ; Hersmus R; Oosterhuis JW; Sun Y; Chen C; Guenther S; Sherlock J; Veltman I; Baeten J; van der Spek PJ; de Alarcon P; Looijenga LH
J Pathol; 2007 Nov; 213(3):319-28. PubMed ID: 17893849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
